| Net Cash Provided by (Used in) Operating Activities |
$20,070,368 |
USD |
5.3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$51,358,465 |
USD |
139% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
17,275,299 |
shares |
165% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$31,288,097 |
USD |
12047% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$70,478,585 |
USD |
404% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$66,354 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,742,997 |
USD |
128% |
Q4 2024 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$1,742,997 |
USD |
128% |
Q4 2024 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,454,652 |
USD |
220% |
Q4 2024 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$890,208 |
USD |
|
Q1 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$268,312,122 |
USD |
153% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$496,839 |
USD |
|
Q1 2024 |
FY 2024 |